Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in adults with genotype 1b chronic hepatitis C and compensated cirrhosis; completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Compensated Cirrhosis
• Hepatitis C

Drugs mentioned

• Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir

Snippet

Sponsor: AbbVie | Conditions: Chronic Hepatitis C Infection, Compensated Cirrhosis | Phase 3 | Status: COMPLETED | Results posted: 2016-06-29